Morgan Stanley lowered the firm’s price target on Cognizant (CTSH) to $80 from $85 and keeps an Equal Weight rating on the shares. The firm lowered its calendar year 2025 organic growth forecast by 100 basis points to 2.4% year-over-year in constant currency as it doesn’t think bookings are showing the modest acceleration its previous estimates contemplated, the analyst tells investors ahead of Cognizant’s investor day on Tuesday, March 25.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CTSH:
- Cognizant’s Growth Outlook Dims Amid Macroeconomic Challenges: Hold Rating Affirmed
- Mantle Ridge Bets $1 Billion on Cognizant as Stock Climbs
- Mantle Ridge establishes more than $1B Cognizant stake, WSJ reports
- Cognizant’s Balanced Outlook: Hold Rating Amid AI Advancements and Uncertain Growth Prospects
- Cognizant’s Strategic Growth and Valuation Advantage Support ‘Buy’ Rating
Questions or Comments about the article? Write to editor@tipranks.com